| A study on the antitumoral and differentiation effects of Peganum harmala derivatives in combination with ATRA on leukaemic cells F Zaker, A Oody, A Arjmand Archives of pharmacal research 30 (7), 844-849, 2007 | 101 | 2007 |
| Diagnosis of factor XIII deficiency A Dorgalaleh, S Tabibian, MS Hosseini, Y Farshi, F Roshanzamir, ... Hematology 21 (7), 430-439, 2016 | 44 | 2016 |
| Congenital factor V deficiency: comparison of the severity of clinical presentations among patients with rare bleeding disorders M Naderi, S Tabibian, S Alizadeh, S Hosseini, F Zaker, T Bamedi, ... Acta haematologica 133 (2), 148-154, 2015 | 38 | 2015 |
| BIBR 1532 increases arsenic trioxide-mediated apoptosis in acute promyelocytic leukemia cells: therapeutic potential for APL D Bashash, S H Ghaffari, F Zaker, M Kazerani, K Hezave, S Hassani, ... Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2013 | 37 | 2013 |
| Direct short-term cytotoxic effects of BIBR 1532 on acute promyelocytic leukemia cells through induction of p21 coupled with downregulation of c-Myc and hTERT transcription D Bashash, SH Ghaffari, F Zaker, K Hezave, M Kazerani, A Ghavamzadeh, ... Cancer investigation 30 (1), 57-64, 2012 | 37 | 2012 |
| Detection of KIT and FLT3 mutations in acute myeloid leukemia with different subtypes F Zaker, M Mohammadzadeh, M Mohammadi ARCHIVES OF IRANIAN MEDICINE 13 (1), 21-25, 2010 | 37 | 2010 |
| TGF-β1–mediated Apoptosis Associated With SMAD-dependent MitochondrialBcl-2 Expression M Bakhshayesh, F Zaker, M Hashemi, M Katebi, M Solaimani Clinical Lymphoma Myeloma and Leukemia 12 (2), 138-143, 2012 | 36 | 2012 |
| Methylenetetrahydrofolate reductase gene polymorphisms and risk of myeloid leukemia P Vahid, R Farnaz, F Zaker, A Farzaneh, R Parisa Laboratory Medicine 41 (8), 490-494, 2010 | 36 | 2010 |
| Association of-24CT, 1249GA, and 3972CT ABCC2 gene polymorphisms with methotrexate serum levels and toxic side effects in children with acute lymphoblastic leukemia MJ Sharifi, G Bahoush, F Zaker, S Ansari, KA Rafsanjani, H Sharafi Pediatric hematology and oncology 31 (2), 169-177, 2014 | 35 | 2014 |
| Inhibitory role of cAMP on doxorubicin-induced apoptosis in pre-B ALL cells through dephosphorylation of p53 serine residues M Safa, A Kazemi, H Zand, A Azarkeivan, F Zaker, P Hayat Apoptosis 15 (2), 196-203, 2010 | 33 | 2010 |
| Central nervous system bleeding in pediatric patients with factor XIII deficiency: A study on 23 new cases M Naderi, S Alizadeh, A Kazemi, S Tabibian, F Zaker, T Bamedi, ... Hematology 20 (2), 112-118, 2015 | 32 | 2015 |
| Polymorphisms within methotrexate pathway genes: Relationship between plasma methotrexate levels, toxicity experienced and outcome in pediatric acute lymphoblastic leukemia MA Esmaili, A Kazemi, M Faranoush, H Mellstedt, F Zaker, M Safa, ... Iranian Journal of Basic Medical Sciences 23 (6), 800-809, 2020 | 27 | 2020 |
| Azidothymidine hinders arsenic trioxide-induced apoptosis in acute promyelocytic leukemia cells by induction of p21 and attenuation of G2/M arrest S Hassani, SH Ghaffari, F Zaker, R Mirzaee, H Mardani, D Bashash, ... Annals of hematology 92 (9), 1207-1220, 2013 | 27 | 2013 |
| Evaluation of T315I mutation frequency in chronic myeloid leukemia patients after imatinib resistance B Chahardouli, F Zaker, SA Mousavi, A Kazemi, M Ostadali, F Nadali, ... Hematology 18 (3), 158-162, 2013 | 26 | 2013 |
| miR-101 sensitizes K562 cell line to imatinib through Jak2 downregulation and inhibition of NF-κB target genes E Farhadi, F Zaker, M Safa, MR Rezvani Tumor Biology 37 (10), 14117-14128, 2016 | 25 | 2016 |
| Serum lipid profiles in acute myocardial infarction patients in Gorgan A Shirafkan, A Marjani, F Zaker Biomedical Research 23 (1), 119-124, 2012 | 25 | 2012 |
| Hematologic and molecular responses to generic imatinib in patients with chronic myeloid leukemia F Razmkhah, M Razavi, F Zaker, A Kazemi, S Negari, P Rasighaemi, ... Laboratory Medicine 41 (9), 547-550, 2010 | 25 | 2010 |
| Chemical characterization and anti‐hemolytic anemia potentials of tin nanoparticles synthesized by a green approach for bioremediation applications A Ahmeda, B Mahdavi, F Zaker, S Kaviani, S Hosseini, MM Zangeneh, ... Applied Organometallic Chemistry 34 (3), e5433, 2020 | 24 | 2020 |
| Frequency of CYP1A1* 2C polymorphism in patients with leukemia in the Iranian population F Razmkhah, V Pazhakh, F Zaker, F Atashrazm, M Sheikhi Laboratory Medicine 42 (4), 220-223, 2011 | 24 | 2011 |
| Detection of nucleophosmin and FMS-like tyrosine kinase-3 gene mutations in acute myeloid leukemia V Pazhakh, F Zaker, K Alimoghaddam, F Atashrazm Annals of Saudi medicine 31 (1), 45-50, 2011 | 22 | 2011 |
